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Vitamin D is a secosteroid hormon with pleiotrophic functions and 
essential for normal development and health throughout the entire life 
span. Vitamin D deficiency has epidemic proportions worldwide and 
interferes with important metabolic processes. Its prevalence is estimated 
in various populations of different etnicity and age from 50% up to 100% in 
certain groups. The main source of vitamin D for men is skin production by 
ultraviolet B radiation acting on 7-dehydrocholesterol. This is cholecalciferol 
or vitamin D3. Less than 20% is obtained from food. The active form, 
1,25-dihydroxy-vitamin D (calcitriol) is synthesized in the kidney. Synthetic 
capacity declines with ageing. The main function of vitamin D is calcium 
homeostasis important for musculosceletal health, innate immunity, 
arterial integrity, endocrine function, antiinflamation, and various local 
processes (autocrine and epicrine functions) in more than 30 tissues where 
receptors exist. Vitamin D is also important for cognitive function, mainly 
executive in the frontal lobe. Normal vitamin D levels are above 75 nmol/L. 
Vitamin D deficiency is mostly due to the lack of sun exposure but can 
also be secondary to some individual characteristics. Deficiency during 
intrauterine development can lead to early and late negative consequences 
in bone growth, immune system, and cognition. The extreme deficiency 
causes rikets. In adults vitamin D deficiency has been suggested as a risk 
factor for infectious and autoimmune diseases, carcinomas (especially of 
the breast and colon), multiple sclerosis, falls, osteoporosis, bone fractures, 
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cardiovacular and cerebrovascular diseases, diabetes mellitus type I and 
II, infertility, cognitive decline and dementia. Oral supplementation with 
serum level normalization can lead to reduction of these risks but even 
amelioration of some pathological states. Recomendation ranges form 400 
IU of vitamin D in infants to 2000 IU in older population, but it should be 
guided by individual clinical circumstances. 
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INTRODUCTION
Vitamin D is a vitamin acting as secosteroid hormone, involved in a 
broad range of metabolical processes, and is crucial for the development and 
maintaining the wellbeing of human organism in all ages (Pavlović, 2012; 
Pludowski et al., 2013). Vitamin D deficiency is broadly present in population 
and causes serious helath hazard if it remains untreated, mostly with long 
term consequences. Low vitamin D levels increase the risk of infectious 
and autoimmune diseases, carcinomas (especially of the breast and colon), 
multiple sclerosis, falls, osteoporosis, bone fractures, cardiovacular diseases, 
diabetes mellitus type I and II, cognitive decline and dementia. 
Estimates are that at least 50% of global population suffer from vitamin 
D deficency (Mithal et al., 2009). The prevalence increases with age, up to 
nearly 100% in some populations with the cutt off of 75 nmol/L (30 ng/
mL) in the population over 65 years (Gouveri et al., 2012). Epidemiological 
data show that the world is facing vitamin D deficiency pandemia in all age 
groups (Rathi & Rathi, 2011). Even the young and healthy are not spared. 
The main source of vitamin D is synthesis in the skin with sun exposure, 
fluctuating according to the length of exposure (lifestile, latitude, climate 
etc.), and less from ingested food. 
Sources of vitamin D
All foods are poor sources of vitamin D, so humans depend on sunlight 
driven processes in the skin. Some amounts of this vitamin are found 
in certain fish. Food and supplements usually contain cholecalciferol 
or ergocalciferol. More than 80% of vitamin D is produced in the skin. 
The substrate is 7-dehydrocholesterol (7-DHC) which under insolation 
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containing ultraviolet B spectrum radiation (UVB; 290–315 nm) 
converts to provitamin D3 that is further converted to vitamin D3 called 
cholecalciferol by local heath (Gouveri et al., 2012; Rathi & Rathi, 2011). 
Vitamin D3 is sythesized by all mammals. Skin production can be limited 
or influenced by the amount of sunlight exposure, latitude, clothing, 
mobility, occupation and personal behavior. Dark skin colour reduces the 
amount of vitamin D production due to UVB absorbtion by melanocytes 
(Clemens et al., 1972). Concentration of 7-dehydrocholesterol, the precursor 
of vitamin D3 in the skin, declines with age, so the capacity of vitamin D 
synthesis is substantialy reduced in old people (Holick & Chen, 2008). 
Vitamin D3 is then transported in the circulation by the vitamin D–
binding protein to the liver and kidney. Liver contains enzyme vitamin D 
25-hydroxylase that converts vitamin D3 to 25(OH)D3 (calcidiol) (Barnard 
& Colón-Emeric, 2010). Ergocalciferol (vitamin D2 – synthesized by plants) 
is converted to 25(OH)D2 also in liver. These are the two metabolites that are 
measured in serum to show vitamin D status. The active form, 1,25-dihydroxy-
vitamin D (calcitriol) is synthesized in the kidney by 1-alpha-hydroxylase 
and is unstable. Calcitriol acts as a hormone, regulating the concentration of 
calcium and phosphate in the blood, supporting the bone and also influencing 
neuromuscular and immune function. The main targets of active vitamin D 
are bones and intestine where it mobilizes osteoclastic activity and enhances 
intestinal calcium absorbtion via VDR (Holick & Chen, 2008). With aging, 
especially after the age of 70, the skin becomes thinner and the ability to 
synthesise vitamin D reduces (Need et al., 1993). 
Risks of too much insolation increase the probability of skin cancers, 
eye diseases and viral infections, as UV light induces immunosuppression 
(Lucas et al., 2006). It has been shown that due to the strength of UV-B 
radiation cutaneous vitamin D synthesis is maximum between 10 AM to 3 
PM when the majority of population is indoors (workin hours, school hours) 
making it less available. Insolation is decreased by air polution, cloud cover, 
increased water vapour and suncreen used as well as cloths cover. Epidermal 
melanin pigment, increased in dark skins protects from skin cancer but 
reduces vitamin D levels absorbing UVR. Vitamin D is delivered to foetus 
from mother via placenta and is essential for intrauterine development. 
Local vitamin D synthesis is found in many non-sceletal tissues where 
it acts localy in autocrine and epicrine manner regulating up to 200 genes 
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(Holick & Chen, 2008). There is some extrarenal production in prostate, 
breast, colon, lung, pancreatic beta cells, monocytes, parathyroid cells, 
endothelial cells and some other tissues (Gouveri et al., 2012).
Mechanisms of action
Vitamin D regulates calcium balance through calcium absorbtion, 
bone mineralisation and general muscle and bone health but has also 
extrasceletal or so called pleiotropic functions. The approximate measure 
of vitamin D storage is serum 25(OH)D level (Rosen, 2011). Vitamin D3 
has also autocrine (acts on the same cell autoreceptors) and paracrine (acts 
on nearby cells) properties and mediates inhibition of cell proliferation, 
promoting of cell differentiation and immune regulation. Vitamin D 
receptors (VDR) are found in the heart, skin, brain, pancreas, prostate, 
breast, immune cells and other tissues, altogether more than 30 (Rathi & 
Rathi, 2011). Autocrine function of vitamin D is nonsceletal and occurs in 
various tissues where it is synthesized. Local calcitriol concentrations are 
higher than serum concentrations. No calcitriol produced locally enters the 
systemic circulation as it is degraded by 24-hydroxylase. Calcitriol acting on 
VDR induces DNA activation resulting in protein production.
Other vitamin D actions are mediated by its effects on endocrine, 
immune and cardiovascular systems, neuropsychological performance and 
neuromuscular functions (Rathi & Rathi, 2011). Vitamin D also possesses 
important antioxidant properties and induces cellular differentiation. 
Hypovitaminosis D undermines the abilities of various tissues to deal 
with stimuli. There are some data on potential role of vitamin D deficiency 
in immunological diseases like multiple sclerosis, diabetes mellitus type 
I, asthma, rheumatoid arthritis and others and infectious diseases also. 
Vitamin D is important in activations of innate immune system which 
explains the importance in aforementioned diseases. Vitamin D protects 
to certain extent against cancers via its prodifferentiation (cell maturation) 
and antiproliferative actions, induction of apoptosis and decreasing 
angiogenesis (Holick & Chen, 2008). Also it has immunomodulatory 
acitivity on monocytes and acitivated T and B lymphocytes.
There are also connections with low vitamin D and children’s health, 
diabetes mellitus type II, arterial hypertension, obesity and vascular 
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diseases. It is still premature to draw definite conclusions about all these 
functions and more randomized controlled studies are needed. 
Vitamin D and the brain
Human brain has the ability to synthesize 1,25-dihydroxyvitamin 
D which is the active form of this vitamin, mostly in the hypothalamus 
and substantia nigra (Eyles et al., 2005). Vitamin D regulates many genes 
important for various functions including neuroprotection modulating 
nerve growth factor, neurotrophin 3, nitric oxide synthase and choline 
acetyl transferase (Balion et al., 2012). It also protects cerebral blood vessels. 
Vitamin D receptors (VDR) can be found in neuronal and glial cells in 
the hippocampus, cortex and subcortex (Annweiler et al., 2010). Vitamin 
D has antiinflammatory capacities and reduces amyloid beta accumulation 
in the brain, reduces toxic oxygen species, stimulates dendritic growth and 
regulates neuronal excitability in the hippocampus (Tuohimaa et al., 2009). 
Vitamin D is crucial for the neurodevelopment with signaling role in 
neuronal differentiation, regulation of neurotrophic factors and neurotoxins 
and protection from inflammation as well as through its endocrine functions 
(Whitehouse et al., 2012). Vitamin D influences also the development of 
perisylvian language area and consequently the development of speech. 
Many neuropsychological studies demonstrated impairments in executive 
functions, particularly in mental shifting and information updating in adults 
with lower vitamin D levels, implying dorsolateral frontal lobe as the brain 
area of importance (Annweiler et al., 2012). 
Vitamin D deficiency
Low serum vitamin D level is associated with all-cause mortality 
(Pludowski et al, 2013). Vitamin D deficiency is defined by most studes as 
the blood level of less than 50 nmol/L and insufficiency as the level between 
50 and 75 nmol/L (Gouveri et al., 2012). Calcium intestine absorption is 
in vitamin D sufficient states between 30-80% and reduces to 10-15% in 
vitamin deficiency that leads to hypocalcaemia and increased parathormone 
(PTH) secretion (Rathi & Rathi, 2011). Consequent processes lead to bone 
Specijalna edukacija i rehabilitacija (Beograd), Vol. 13, br. 1. 117-132, 2014.
122
demineralization with rickets in children and osteomalacia in adults. But 
there is also growing body of information on importance of subclinical 
vitamin D deficiency, especially in nonsceletal functions. 
The main reason for vitamin D deficiency is insufficient sun exposure, 
but on the other hand excessive insolation introduces various health 
hazards making it challenging to determine safe practices. Foods are 
generaly poor sources of vitamin D. Also, diet rich in fibres and low 
calcium level depletes vitamin D storage in the organism. There are also 
some genetic factors, mostly in South Asians and African Americans 
(Rathi & Rathi, 2011).
It has been shown that certain drugs such as antiepileptics and 
glucocorticoids can cause vitamin D deficiency (Holick & Chen, 
2008). Malabsorbtion leads to vitamin D hypovitaminosis as well. 
Hypovitaminosis D can lead to secondary hyperparathyroidism as the 
paratyroid glands tend to compensate for low calcium. This can be the cause 
of high calcium so one should always be alert and not wrongly diagnose 
primary hyperthyroidism before vitamin D level has been normalized. In 
secondary hyperpartyrodism, parathormone levels will drop to normal. 
Obese people tend to have lower vitamin D serum levels as most of the 
vitamin is seqestrated in fat cells (liposoluble vitamin!) and also because of 
the reduced mobility, excersizing and sun exposure. 
Vitamin D deficiency should be considered if a patient is presented with 
risk factors and appropriate signs and symptoms. Known risk factors are 
shown in Table 1. Laboratory findings of low calcium, low phosphate or 
raised alkaline phosphatase shoud prompt vitamin D serum determination.
Table 1 – Common risk factors for vitamin D deficiency
older age (>65 years)
children under 5 years of age
vegan/vegetarian diet
intestinal malabsorption (coeliac disease, 
Crohn’s disease, gastrectomy, cholestatic liver)
darker skin coloration liver or renal disease
predominantly indoor activities 
regular use of high factor 
sunscreen (15 or above) 
covering whole body in clothes
medications: anticonvulsants, cholestyramine, 
colestipol, rifampicin, glucocorticoids, highly 
active antiretrovirals
obesity (BMI >30) pregnancy, short interval pregnancies, breastfeeding
Pavlović, M.D., Pavlović, M.A.: Vitamin D across the life span
123
Important influence of vitamin D on human development begins 
during intrauterine period when fetus is completely dependent on vitamin 
from maternal circulation. This means that maternal serum vitamin D is a 
good measure for vitamin availability for the fetus. Low maternal vitamin 
D serum levels do not correlate with offspring behavioral and emotional 
problems but are associated with language impairment at 5 and 10 years of 
age, growth-restriction, reduced bone accrual and wheeze (Whitehouse et 
al., 2012). There is also an increased risk for multiple sclerosis in children 
whose mothers were in the first and second trimesters of pregnancy during 
winter and spring months (Staples et al., 2010). Low serum vitamin D 
levels in women are associated with infertility and preeclampsia (Rathi & 
Rathi, 2011; Holick & Chen, 2008). Physiological states as pregnancy and 
lactation incease the needs for vitamin D and makes deficiency more likely. 
Vitamin D deficiency in infants is frequent and can hardly be counteracted 
by mother milk alone without supplements and sun exposure of the child 
(Rathi & Rathi, 2011).
Rickets is associated with an elevated serum alkaline phosphatase, 
elevated serum parathyroid hormone, low 25(OH)D, low or low normal 
serum phosphorus and either a normal or low serum level of calcium 
(Pludowski et al., 2013). Severe vitamin D deficiency results in hypocalcaemia 
with seizures and weak bones prone to fractures. Rickets is seen from infant 
period up to adolescence with peak incidence between 3 and 18 months 
of age (Wagner et al., 2008). Children manifest letargy, irritability, growth 
failure and are prone to respiratory infections. There are three stages 
of vitamin D deficiency. In the first stage 25-OH-D level decreases, with 
consequent hypocalcemia and euphosphatemia while 1,25-OH2-D may 
increase or remain unchanged. In the second stage, 25-OH-D level are even 
lower but there is compensation as PTH increases calcium mobilizing from 
bones, as a result of which there is eucalcemia and hypophosphatemia. 
In stage three, there is severe 25-OH-D deficiency with hypocalcemia and 
hypophosphatemia. There is skull enlargement, legs skeletal malformations 
of varus and valgus type and other deformities. 
There is another, less known consequence of vitamin D deficiency in 
young people with diabetes mellitus type I (Kaur et al., 2011). It has been 
found that hypovitaminosis D is associated with an increased prevalence 
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of retinopathy due to inflammatory and angiogenic effects. Low levels of 
vitamin D have been associated with asthma (Bose et al., 2013). 
Low vitamin D can trigger certain autoimmune disorders as it might 
play a role in the regulation of auto-antibodies production via T-helper 
cell modulation and induction of CD4+CD25high regulatory T-cells. 
Interestingly, it has been shown that autistic children have significantly 
lower serum levels of 25-hydroxy vitamin D than healthy children and 
anti-MAG auto-antibodies are found in 70% of autistic patients (Mostafa 
& Al-Ayadhi, 2012). 
Epidemiological studies from the United States before World War II 
showed positive correlation between higher latitudes and occurence of 
common malignancies (Apperly, 1941). Subsequent papers reported similar 
results with incresed risk of breast, colon, prostate, pancreatic, oesophageal, 
non-Hodgkin lymphoma and other cancers conected with low serum 
vitamin D (Holick & Chen, 2008). It can been suggested that lower levels 
of vitamin D3 production because of progressively less sunlight in higher 
latitudes are the reason for these findings. The risk is present both in men 
and women. With daily supplementation of 400 IU to 1000 IU there was a 
substantial risk reduction of cancer (Holick & Chen, 2008).
Higher latitudes and low vitamin D status have also been connected with 
the increased risk of autoimmune desease such as multiple sclerosis, diabetes 
mellitus type I, rheumatoid arthritis, systemic lupus erithematosus and 
psoriasis (Holick & Chen, 2008; Wagner et al., 2008). Deficiency has been also 
linked to arterial hypertension (Holick, 2006). Increased intake of vitamin D 
preparations was followed by reduction of forementioned conditions (Holick, 
2006). Innate immune system enhancing and antiinflamatory properties are 
the probable explanation. This is also true for infectious diseases such as 
tuberculosis. The predomance of environmental factors over genetic factors 
is supported by studies in identical twins (Islam et al., 2007). The current 
hypothesis is that certain genetic fators can be influenced by vitamin D levels 
during childhood leading to activation of immune system, production of 
autoantiboides and nerve tissue lesions. Several studies showed that vitamin 
D supplementation reduces risk of relapses. 
Vitamin D deficiency is an independent risk factor for lower bone density, 
falls and fractures. It has been found that vitamin D supplementation 
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greater than 700 IU a day appears to decrease falls by approximately 
20% (Bischoff-Ferrari et al., 2009). Falls seem to be more due to cognitive 
changes than to gait contribution to instability, but vitamin D deficiency 
also leads to proximal muscle weakness. Patients with osteomalacia 
complain of bone discomfort and pains in joints and muscles due to 
mineralization defect (Holick & Chen, 2008). Moreover, people with non-
specific musculoskeletal pain, chronic low back pain or fibromyalgia have 
lower vitamin D levels and might improve with supplementation. 
Recent studies showed interaction of vitamin D and cognitive functions. 
Lower vitamin D concentrations correlate with the decline of cognitive 
function both in nondemented and demented subjects (Balion et al., 2012; 
Pavlović, 2013). This can be the result of increase of inflammatory processes, 
hyperoxidation and disregulation of hippocampal excitabilty among other 
possible mechanisms (Tuohimaa et al., 2009). Positive correlations that have 
been found between vitamin D serum levels and cognitive status warrants 
therapeutic trials (Briones & Darwish, 2012). There is ongoing unicentre, 
double-blind, randomized, placebo-controlled, intent-to-treat, superiority 
trial of treating demented patients with combination of memantine, an 
antidementia drug, and vitamin D supplementation as a new multi-target 
therapeutic class for the treatment of Alzheimer’s disease (Annweiler 
et al., 2011). The rationale for such treatment are multitarget actions of 
vitamin D on causes of neurodegeneration as it has immunoregulatory, 
antioxidant and anti-ischemic actions. It also regulates neurotrophic 
factors, acetylcholine neurotransmitter, clearance of amyloid beta peptide 
and other functions (Annweiler & Beauchet, 2011). VDR polymorphisms 
are associated with late onset Alzheimer’s disease (Gezen-Ak et al., 2012). 
Another neurodegenerative disease, Parkinson’s disease is influenced 
by vitamin D (Butler et al., 2011). VDR gene is the most probable 
susceptibility gene playing an importante role in Parkinson’s disease with 
varous polymorphisms (Gezen-Ak et al., 2012). 
Vitamin D serum levels are inversely correlated with depression 
according to several studies (Barnard & Colón-Emeric, 2010). Vitamin 
D supplementation for a year did not have adverse effects and showed 
improvement in measures of depression in one study but there were still 
some methodological issues so these results warrant confirmation studies. 
Besides, some studies found correlation between poor vitamin D status 
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and schizophrenia (Holick & Chen, 2008). The recent trial in patients with 
schizophrenia showed significantly lower vitamin D serum concentrations 
than in depressed and psychiatrically healthy controls (Itzhaky et al., 
2012). This might be the manifestation of autoimmune mechanims. VDR 
polymorphisms can also be important as they have been implicated in 
behavioral control and regulation. Vitamin D supplementation during 
pregnancy and during infancy and early childhood have positive effects on 
mental functioning. 
Vitamin D influences arteries both directly and via methabolic factors 
(Gouveri et al., 2012). Low levels of vitamin D are associated with risk for 
diabetes mellitus, arterial hypertension, hyperlipidemia, metabolic syndrome 
and central and peripheral arterial disease. Therefore, the deficiency can lead 
to myocardial infarction and stroke, peripheral arterial disease and possibly 
increase overall mortality. Vitamin D down-regulates pro-inflammatory 
cytokines, and up-regulates anti-inflammatory cytokines, it regulates 
the production of multiple proteins in the vascular wall and also inhibits 
cholesterol uptake by macrophages, preventing foam cell formation and 
the process of atheroslcerosis (Gouveri et al., 2012). Potential therapeutical 
effects of vitamin D supplementation are still controversial.
Supplementation and therapeutical doses
Supplementation with vitamin D preparations has protective and 
possibly therapeutic properties in a range of diseases. It has a potential 
role in prevention of musculoskeletal disorders, infectious diseases, 
autoimmune diseases, cardiovascular disease, type I and type II diabetes 
mellitus, different cancers, cognition and mental illness, infertility and 
complications of pregnancy (Pludowski et al., 2013). 
Diagnosis of vitamin D deficiency relies on serum 25(OH)D level as it is 
the storage form of vitamin D and has mush longer half life (Rathi & Rathi, 
2011). One should not rely on 1,25(OH)2D levels because hypocalcemia 
induces parathormone (PTH) production and pseudonormal serum levels 
of vitamin D. The golden standard for laboratory diagnostics is liquid 
chromatography–tandem mass spectroscopy.
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Recomended daily intake doses vary but according to recent US 
Endocrine Society’s Clinical Practice Guideline for children under a year it 
is 400–1000 IU daily, for children over one year 600–1000 IU daily and for 
adults over 19 years 1500–2000 IU for keeping the vitamin D level above the 
optimal cut-off of 75 nmol/L (Pramyothin & Holick, 2012). There are various 
units of measure: 400 international units (IU) equals 10 mcg or 26 nmol 
(Rathi & Rathi, 2011). Some other recommendations are more conservative, 
suggesting 400 IU daily of vitamin D3 for infants, children and adolescents 
with progressively higher tolerable upper level with maturation (Wagner 
et al., 2008). Vitamin D2 is also effective in treating vitamin D defficiency 
but may need somewhat higher doses than D3 supplementation. In plants 
and yeast, vitamin D2 is obtained from UVB influence and is used for 
supplementation production (Rathi & Rathi, 2011).
In some Western industrialized countries fortification of milk and 
other foods with vitamin D has become a routine practice unlike other 
countries leading to less hypovitaminosis and its consequences (Marwaha 
& Sripathy, 2008). Unanswered questions are weather such supplementation 
can also correct subclinical deficiencies and if there are any unwanted 
effects. Populations with higher frequency of hypovitaminosis D tend to 
suffer more from osteoporosis ant osteoporotic bone fractures. Vitamin D 
and calcium supplementation reduces the risk of falls and fractures. 
For therapeutical purposes both D2 and D3 are used, while 1-alphacalcidol 
is not appropriate for treating vitamin D deficiency. Daily doses are between 
1000 IU and 10,000 IU. There are also different protocols with once a week 
high doses for several months. Vitamin D supplies are usually restored in about 
three months and then the maintenance doses can be introduced, usually 800-
1000 IU daily (D2 or D3) (Rathi & Rathi, 2011; Holick & Chen, 2008).
Sun exposure can not lead to hypervitaminosis D so moderate outdoors 
activites are of favourable effect for all ages. (Wagner et al., 2008). Individuals 
with darker pigmentation require 5 to 10 times more sunlight exposure than 
adults with lighter pigmentation. It is hard to determine the right amount of 
insolation for any particular individual but outdoor activities are favourable. 
Another possibility is artificial UVB radiation. Oral supplementation is 
better option and intoxication is very rare. 
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Vitamin D toxicity occurs after excessive supplementation for several 
months and not due to excessive sun exposure (Ross et al., 2011). According 
to currently available evidence, adverse affects can be encountered in serum 
vitamin D levels of >150 nmol/L (>60 ng/mL). Toxic daily doses are above 
10,000 IU. High level of vitamin D (especially over 250 nmol/L i.e. 100 ng/
mL) are followed by hypercalcaemia with possible changes in heart rate, 
headaches and gastrointestinal disturbances, kidney stones and kidney 
failure and growth restriction in children. In bone complications due to 
vitamin D depletion, calcium should be co-supplemented with vitamin D 
(Rathi & Rathi, 2011). 
CONCLUSION
Epidemic proportions of vitamin D deficiency have been recognized 
worldwide. Vitamin D interferes with important metabolic processes, 
influencing calcium homeostasis and affecting musculosceletal health, innate 
immunity, arterial integrity, endocrine function and antiinflamatatory 
mechanisms in more than 30 tissues where its receptors exist, including the 
brain. Deficiency during intrauterine development can lead to serious sequelae 
in bone growth, immune system and cognition, while extreme deficiency leads 
to rikets. In adults, vitamin D deficiency has been identified as a risk factor 
for infectious and autoimmune diseases, carcinomas, multiple sclerosis, falls, 
osteoporosis, bone fractures, cardiovacular and cerebrovascular diseases, 
diabetes mellitus type I and II, infertility, cognitive decline and dementia. Oral 
supplementation with serum level normalization can be beneficial in reducting 
these risks and even lead to amelioration of certain pathological conditions. 
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Sažetak
Vitamin D je sekosteroidni hormon sa pleotropnim funkcijama i 
presudan za pravilan razvoj i zdravlje kroz ceo životni vek. Nedostatak 
vitamina D ima razmere epidemije širom sveta i ometa važne metaboličke 
procese. Procene u različitim populacijama različitog etničkog porekla i 
starosti su od 50% do 100 % u pojedinim grupama. Glavni izvor vitamina 
D kod ljudi je sinteza u koži pod dejstvom ultraljubičastog B zračenja na 
7- dehidrocholesterol. To je vitamin D3 ili holekalciferol. Manje od 20% 
se dobija iz hrane. Aktivni oblik, 1,25-dihidroksi- vitamin D (kalcitriol) 
se sintetiše u bubrezima. Sintetički kapaciteta opada sa starenjem. Glavna 
funkcija vitamina D je homeostaza kalcijuma, zdravlje muskuloskeletnog 
sistema, urođeni imunitet, integritet arterija, endokrine funkcije, antiin-
flamatorno dejstvo i različiti lokalni procesi (autokrine i epikrine funkcije) 
u više od 30 tkiva gde postoje receptori. 
Vitamin D je takođe važan za kognitivne funkcije, uglavnom egzeku-
tivne u frontalnom režnju. Normalni nivoi vitamina D su iznad 75 nmol/L. 
Nedostatak vitamina D je uglavnom uzrokovan nedostatkom sunčeve 
svetlosti, ali i nekih individualnih karakteristika bolesnika. Nedostatak 
tokom intrauterinog razvoja može da dovede do ranih i kasnih negativnih 
posledica na rast kostiju, imuni sistem i kogniciju. Ekstremni nedostatak 
vitamin D izaziva rahitis. Kod odraslih je nedostatak vitamina D faktor 
rizika za infektivne i autoimune bolest, karcinome (naročito dojke i debe-
log creva), multiplu sklerozu, padove, osteoporozu, prelome kostiju, kardio-
vakularna i cerebrovaskularna oboljenja, dijabetes melitus tip I i II, neplod-
nost, kognitivni pad i demencije. Oralna suplementacija sa normalizacijom 
nivoa vitamina u serumu može da dovede do smanjenja ovih rizika ali čak 
i ublažavanje nekih patoloških stanja. Preporučene doze iznose od 400 IU 
vitamina D kod odojčadi do 2000 IU u starijoj populaciji, ali bi trebalo da 
se rukovodi individualnim kliničkim okolnostima.
Ključne reči: vitamin D, kognicija, imunitet, ultravioletna B radijacija
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